The life science industry is confronted with financial challenges and business model disruption. To name just a few, whether they need to accelerate product innovation, engage in commercial transformation or develop analytics-driven care management, success in any area will also depend on technology and access to information. With 80-90 % of the world's current data created in the past two years and less than 1 % currently being analyzed, 7'000 medical research papers written every day and the prediction that the entire medical corpus will double every 73 days by 2020, humans need support.
In this workshop IBM Watson Health will present three selected key solutions supporting life science companies to achieve their goals:
15.00 Intro IBM Watson Health
15.15 Watson for Drug Discovery
Speaker: Grant Robertson, Watson Health Life
Science Consultant, London/GB
16.00 Coffee break
16.30 Real World Evidence
Speaker: Peter Hasse, Watson Health
Senior Consultant, St.Louis/USA
17.15 Identifizierung von Key Opinion Leader
Speaker: Jan-Philipp Royl, Country Director D/A
Truven Health Analytics (an IBM company),
End of workshop around 18.15
Venue and time:
Thursday, March 23, 2017; 15:00 - 18:15 hrs
at BioM Biotech Cluster Development GmbH
(IZB West II, 3rd floor)
Am Klopferspitz 19 a, D-82152 Martinsried
This IBM event is free of charge,
but registration is necessary.
Please register here.
Further information about Watson Health